Comparable effect of tolvaptan in heart failure patients with preserved or reduced ejection fraction-Reference-Cited by-同舟云学术

Comparable effect of tolvaptan in heart failure patients with preserved or reduced ejection fraction

Published:2019-02-22 Issue:2 Volume:42 Page:110-117
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Kiuchi Shunsuke¹,Hisatake Shinji¹,Kabuki Takayuki¹,Oka Takashi¹,Dobashi Shintaro¹,Fujii Takahiro¹,Ikeda Takanori¹

Affiliation:

1. Department of Cardiovascular Medicine, Toho University Graduate School of Medicine, Tokyo, Japan

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10641963.2019.1583244

Reference36 articles.

1. Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload Despite the Standard Treatment with Conventional Diuretics: A Phase III, Randomized, Double-blind, Placebo-controlled Study (QUEST Study)

2. Low Cardiac Output Stimulates Vasopressin Release in Patients With Stage D Heart Failure

3. Early use of V2 receptor antagonists is associated with a shorter hospital stay and reduction in in-hospital death in patients with decompensated heart failure

4. The relationship between the time until commencement of tolvaptan and the length of hospital stay in heart failure patients

5. Tsutsui H, Isobe M, Ito H, JCS Joint Working Group (2017) Guidelines for diagnosis and treatment of acute and chronic heart failure (JCS 2017/JHFS 2017).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscape;Heart Failure Reviews;2024-02-27

2. Old and New Drugs for Treatment of Advanced Heart Failure;Current Pharmaceutical Design;2020-05-15